Medgadget

Smartphone and Cheap Earbuds for Accessible Newborn Hearing Test

Researchers at the University of Washington have developed a low-cost hearing test for newborns. Traditionally, the equipment for such testing is quite expensive. As newborns cannot let us know if they can hear something, the test is based on creating a noise within the ear canal and then listening to the vibrations created by the specialized hair cells within.

Improved Membrane Coating for Anti-Cancer Nanoparticles

Scientists at the University of Eastern Finland have developed a technique that lets them improve the coating of nanoparticles when using cell membranes. Cell membranes offer a lot of benefits as a coating for synthetic nanoparticles, including shielding from the immune system, prolonged circulation times and improved tumor accumulation. However, current approaches to coating nanoparticles with cell membranes often result in an incomplete covering.

Symani Microsurgical Robotic System: Interview with Mark Toland, CEO of Medical Microinstruments

Medical Microinstruments, a medtech company with offices in Pisa, Italy and Delaware, USA, has developed the Symani Microsurgical Robot. The robotic system is designed to assist with microsurgical procedures, and it boasts a variety of advanced features to achieve this goal.

Micelle Technology Detects Airborne SARS-CoV-2

At the Pacific Northwest National Laboratory, researchers have developed micelle technology that can detect minute amounts of SARS-CoV-2 in the air. This new capability could provide invaluable monitoring systems to detect viral contamination in healthcare facilities and beyond. Micelles are somewhat similar to liposomes in that they are both like tiny lipid bubbles. In this instance, the researchers incorporated molecularly imprinted polymer molecules into the wall of the micelles. These molecularly imprinted molecules can bind to the viral spike protein.

AI-Enhanced Prostate Cancer Treatment: Interview with Brittany Berry-Pusey, Co-Founder and COO at Avenda Health

Avenda Health, a medtech company based in Santa Monica, California has developed the FocalPoint ablation system, an AI-powered prostate cancer therapy. The system is designed to provide localized prostate cancer treatment and its AI system equips clinicians with a map of a patient’s cancer, along with treatment simulations to help them chose the best course of action.